HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Anti TNF-α (infliximab) treatment for intravenous immunoglobulin (IVIG) resistance patients with acute Kawasaki disease the effects of anticytokine therapy].

Abstract
Among the patients with acute Kawasaki disease treated with intravenous immunoglobulin (IVIG), 10-20 % demonstrate resistance or incomplete effects. Cardiac complication such as the coronary arterial aneurysm is frequent in these patients. For patients with IVIG-resistance, we have surveyed the efficacy and safety of anti-cytokine therapy with use of infliximab (Remicade), chimera type anti TNF-α agent, for children. After May, 2005, Remicade has been used in >500 pediatric patients in whom IVIG and intravenous methylprednisolone pulse therapy did not show significant effects. The efficacy and safety of Remicade on patients with IVIG-resistant Kawasaki disease has been observed but 10~20 % of patients was Remicade-resistant. Re-treatment with IVIG or steroids was also effective. The efficacy of Remicade for reducing the fever duration, CRP, WBC counts was promising, but reduction of the incidence of coronary aneurysm was not confirmed. Randomized clinical trial will be needed.
AuthorsTsutomu Saji, Shinichi Takatsuki, Toru Kobayashi
JournalNihon rinsho. Japanese journal of clinical medicine (Nihon Rinsho) Vol. 72 Issue 9 Pg. 1641-9 (Sep 2014) ISSN: 0047-1852 [Print] Japan
PMID25518416 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Antibodies, Monoclonal
  • Immunoglobulins, Intravenous
  • Tumor Necrosis Factor-alpha
  • Infliximab
Topics
  • Acute Disease
  • Antibodies, Monoclonal (adverse effects, therapeutic use)
  • Drug Resistance
  • Humans
  • Immunoglobulins, Intravenous (therapeutic use)
  • Infliximab
  • Mucocutaneous Lymph Node Syndrome (drug therapy, immunology)
  • Tumor Necrosis Factor-alpha (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: